75 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
Indebtedness Amount.
“Action” means any action, suit, claim, litigation, arbitration or proceeding, or any investigation of which Seller has Knowledge … routine claims for benefits in the ordinary course of business, and (ii) none of the Benefit Plans is under audit, inquiry, proceeding, investigation
424B3
ssxvuucvbj
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
mclf50tn
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
arcu4a frb
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
wiinb5 re
16 Jun 23
Business combination disclosure
8:08am
425
b0doru04hgn rstl
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
gnukcdi0j397prmq ad
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
6vetnpiv31ebms6
18 May 23
Other Events
5:02pm